المؤلفون: Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Karbiener M; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Knotzer S; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Schwaiger J; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.

المصدر: The Journal of infectious diseases [J Infect Dis] 2022 Oct 17; Vol. 226 (8), pp. 1396-1400.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Neutralizing*/immunology , COVID-19*/immunology , SARS-CoV-2*, Antibodies, Viral ; Europe ; Humans ; Neutralization Tests ; Spike Glycoprotein, Coronavirus ; United States

SCR Organism: SARS-CoV-2 variants

المؤلفون: Dodd RY; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA., Notari EP; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA., Brodsky JP; Quality Analytics, Deerfield, Illinois, USA., Foster GA; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA., Xu M; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA., Saá P; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA., Stramer SL; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA.

المصدر: The Journal of infectious diseases [J Infect Dis] 2022 Jan 05; Vol. 225 (1), pp. 5-9.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antibody Formation* , Blood Donors*, Antibodies, Neutralizing/*blood , Antibodies, Viral/*blood , COVID-19/*prevention & control , COVID-19 Vaccines/*administration & dosage , SARS-CoV-2/*isolation & purification, Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19/epidemiology ; COVID-19 Testing ; Female ; Humans ; Male ; Middle Aged ; SARS-CoV-2/immunology ; Spike Glycoprotein, Coronavirus ; United States/epidemiology ; Vaccination ; Young Adult

المؤلفون: Killerby ME; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ata Ur Rasheed M; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Tamin A; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Harcourt JL; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Abedi GR; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Lu X; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kujawski S; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Shah MM; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kirking HL; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gold JAW; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Salvatore PP; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Coughlin MM; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Whitaker B; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Tate JE; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Watson JT; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Lindstrom S; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Hall AJ; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Fry AM; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gerber SI; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Midgley CM; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Thornburg NJ; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

المصدر: The Journal of infectious diseases [J Infect Dis] 2021 Sep 01; Vol. 224 (5), pp. 771-776.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Neutralizing/*immunology , Antibodies, Viral/*immunology , Antibody Formation/*immunology , COVID-19/*immunology , Seroconversion/*physiology, Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; COVID-19/blood ; COVID-19/virology ; Follow-Up Studies ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Spike Glycoprotein, Coronavirus/immunology ; United States